{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:07:20Z","timestamp":1784171240709,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM092218"],"award-info":[{"award-number":["R01 GM092218"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM065086"],"award-info":[{"award-number":["T32 GM065086"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM065086"],"award-info":[{"award-number":["T32 GM065086"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM133552"],"award-info":[{"award-number":["R35 GM133552"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA226833"],"award-info":[{"award-number":["R01 CA226833"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F30 CA236131"],"award-info":[{"award-number":["F30 CA236131"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F30 CA247202"],"award-info":[{"award-number":["F30 CA247202"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL138291"],"award-info":[{"award-number":["K23 HL138291"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT162186"],"award-info":[{"award-number":["PJT162186"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41589-021-00900-9","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:08:02Z","timestamp":1638446882000},"page":"360-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase"],"prefix":"10.1038","volume":"18","author":[{"given":"Benjamin J.","family":"Reisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley E.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley I.","family":"Reinfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-9154","authenticated-orcid":false,"given":"P. Brent","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Sulikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Kimryn","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Savona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Plate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-1176","authenticated-orcid":false,"given":"Brian O.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.chembiol.2021.01.026","volume":"28","author":"Y Akimov","year":"2021","unstructured":"Akimov, Y. & Aittokallio, T. Re-defining synthetic lethality by phenotypic profiling for precision oncology. Cell Chem. Biol. 28, 246\u2013256 (2021).","journal-title":"Cell Chem. Biol."},{"key":"900_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"900_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis, R. J. & Chandel, N. S. We need to talk about the Warburg effect. Nat. Metab. 2, 127\u2013129 (2020).","journal-title":"Nat. Metab."},{"key":"900_CR5","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.1021\/acs.jmedchem.0c01013","volume":"63","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Xue, D., Bankhead, A. 3rd & Neamati, N. Why all the fuss about oxidative phosphorylation (OXPHOS)? J. Med. Chem. 63, 14276\u201314307 (2020).","journal-title":"J. Med. Chem."},{"key":"900_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","volume":"585","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I. et al. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature 585, 288\u2013292 (2020).","journal-title":"Nature"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones, C. L., Inguva, A. & Jordan, C. T. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell 28, 378\u2013393 (2021).","journal-title":"Cell Stem Cell"},{"key":"900_CR8","doi-asserted-by":"publisher","first-page":"114253","DOI":"10.1016\/j.bcp.2020.114253","volume":"182","author":"JL Carter","year":"2020","unstructured":"Carter, J. L. et al. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia. Biochem. Pharmacol. 182, 114253 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"900_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"900_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei, S. et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 10, 536\u2013551 (2020).","journal-title":"Cancer Discov."},{"key":"900_CR11","doi-asserted-by":"publisher","first-page":"109024","DOI":"10.1016\/j.celrep.2021.109024","volume":"35","author":"D Sighel","year":"2021","unstructured":"Sighel, D. et al. Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth. Cell Rep. 35, 109024 (2021).","journal-title":"Cell Rep."},{"key":"900_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1234769","volume":"340","author":"F Wang","year":"2013","unstructured":"Wang, F. et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 340, 622\u2013626 (2013).","journal-title":"Science"},{"key":"900_CR13","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & Deberardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"900_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.7164\/antibiotics.50.628","volume":"50","author":"JW Kim","year":"1997","unstructured":"Kim, J. W., Adachi, H., Shin-ya, K., Hayakawa, Y. & Seto, H. Apoptolidin, a new apoptosis inducer in transformed cells from Nocardiopsis sp. J. Antibiot. (Tokyo) 50, 628\u2013630 (1997).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"900_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7164\/antibiotics.54.710","volume":"54","author":"R Murakami","year":"2001","unstructured":"Murakami, R. et al. Ammocidin, a new apoptosis inducer in Ras-dependent cells from Saccharothrix sp. I. Production, isolation and biological activity. J. Antibiot. (Tokyo) 54, 710\u2013713 (2001).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"900_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-5521(00)00057-0","volume":"8","author":"AR Salomon","year":"2001","unstructured":"Salomon, A. R., Voehringer, D. W., Herzenberg, L. A. & Khosla, C. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chem. Biol. 8, 71\u201380 (2001).","journal-title":"Chem. Biol."},{"key":"900_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1021\/ol052800q","volume":"8","author":"PA Wender","year":"2006","unstructured":"Wender, P. A. et al. Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues. Org. Lett. 8, 589\u2013592 (2006).","journal-title":"Org. Lett."},{"key":"900_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bcp.2014.11.015","volume":"93","author":"JD Serrill","year":"2015","unstructured":"Serrill, J. D. et al. Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A. Biochem. Pharmacol. 93, 251\u2013265 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"900_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/anie.201408906","volume":"54","author":"SM DeGuire","year":"2015","unstructured":"DeGuire, S. M. et al. Fluorescent probes of the apoptolidins and their utility in cellular localization studies. Angew. Chem. Int. Ed. 54, 961\u2013964 (2015).","journal-title":"Angew. Chem. Int. Ed."},{"key":"900_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/9780470559277.ch090167","volume":"1","author":"AL Mackinnon","year":"2009","unstructured":"Mackinnon, A. L. & Taunton, J. Target identification by diazirine photo-cross-linking and click chemistry. Curr. Protoc. Chem. Biol. 1, 55\u201373 (2009).","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"900_CR21","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1016\/j.tet.2011.05.106","volume":"67","author":"Y Du","year":"2011","unstructured":"Du, Y. et al. Biosynthesis of the apoptolidins in Nocardiopsis sp. FU 40. Tetrahedron 67, 6568\u20136575 (2011).","journal-title":"Tetrahedron"},{"key":"900_CR22","doi-asserted-by":"publisher","first-page":"14766","DOI":"10.1073\/pnas.97.26.14766","volume":"97","author":"AR Salomon","year":"2000","unstructured":"Salomon, A. R., Voehringer, D. W., Herzenberg, L. A. & Khosla, C. Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F0F1-ATPase. Proc. Natl Acad. Sci. USA 97, 14766\u201314771 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"900_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1021\/ol027366w","volume":"5","author":"PA Wender","year":"2003","unstructured":"Wender, P. A., Jankowski, O. D., Tabet, E. A. & Seto, H. Toward a structure\u2013activity relationship for apoptolidin: selective functionalization of the hydroxyl group array. Org. Lett. 5, 487\u2013490 (2003).","journal-title":"Org. Lett."},{"key":"900_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/370621a0","volume":"370","author":"JP Abrahams","year":"1994","unstructured":"Abrahams, J. P., Leslie, A. G., Lutter, R. & Walker, J. E. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. Nature 370, 621\u2013628 (1994).","journal-title":"Nature"},{"key":"900_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.sbi.2018.08.005","volume":"52","author":"H Guo","year":"2018","unstructured":"Guo, H. & Rubinstein, J. L. Cryo-EM of ATP synthases. Curr. Opin. Struct. Biol. 52, 71\u201379 (2018).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"900_CR26","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1021\/jacs.1c02509","volume":"143","author":"AV West","year":"2021","unstructured":"West, A. V. et al. Labeling preferences of diazirines with protein biomolecules. J. Am. Chem. Soc. 143, 6691\u20136700 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"900_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/ol006767d","volume":"3","author":"AR Salomon","year":"2001","unstructured":"Salomon, A. R., Zhang, Y., Seto, H. & Khosla, C. Structure\u2013activity relationships within a family of selectively cytotoxic macrolide natural products. Org. Lett. 3, 57\u201359 (2001).","journal-title":"Org. Lett."},{"key":"900_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1042\/BST0340989","volume":"34","author":"JR Gledhill","year":"2006","unstructured":"Gledhill, J. R. & Walker, J. E. Inhibitors of the catalytic domain of mitochondrial ATP synthase. Biochem. Soc. Trans. 34, 989\u2013992 (2006).","journal-title":"Biochem. Soc. Trans."},{"key":"900_CR29","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1073\/pnas.1207912109","volume":"109","author":"J Symersky","year":"2012","unstructured":"Symersky, J., Osowski, D., Walters, D. E. & Mueller, D. M. Oligomycin frames a common drug-binding site in the ATP synthase. Proc. Natl Acad. Sci. USA 109, 13961\u201313965 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"900_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3550","volume":"4","author":"M Tantama","year":"2013","unstructured":"Tantama, M., Martinez-Francois, J. R., Mongeon, R. & Yellen, G. Imaging energy status in live cells with a fluorescent biosensor of the intracellular ATP-to-ADP ratio. Nat. Commun. 4, 2550 (2013).","journal-title":"Nat. Commun."},{"key":"900_CR31","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.1073\/pnas.0707326104","volume":"104","author":"JR Gledhill","year":"2007","unstructured":"Gledhill, J. R., Montgomery, M. G., Leslie, A. G. & Walker, J. E. How the regulatory protein, IF1, inhibits F1-ATPase from bovine mitochondria. Proc. Natl Acad. Sci. USA 104, 15671\u201315676 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"900_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"900_CR33","first-page":"e1","volume":"48","author":"KA Matreyek","year":"2020","unstructured":"Matreyek, K. A., Stephany, J. J., Chiasson, M. A., Hasle, N. & Fowler, D. M. An improved platform for functional assessment of large protein libraries in mammalian cells. Nucleic Acids Res. 48, e1 (2020).","journal-title":"Nucleic Acids Res."},{"key":"900_CR34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nmeth.4029","volume":"13","author":"EE Wrenbeck","year":"2016","unstructured":"Wrenbeck, E. E. et al. Plasmid-based one-pot saturation mutagenesis. Nat. Methods 13, 928\u2013930 (2016).","journal-title":"Nat. Methods"},{"key":"900_CR35","unstructured":"Smith, R. M. Biological and chemical studies on a new antibiotic, oligomycin, University of Wisconsin\u2013Madison, (1953)."},{"key":"900_CR36","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1021\/ol026829v","volume":"4","author":"JD Pennington","year":"2002","unstructured":"Pennington, J. D., Williams, H. J., Salomon, A. R. & Sulikowski, G. A. Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin. Org. Lett. 4, 3823\u20133825 (2002).","journal-title":"Org. Lett."},{"key":"900_CR37","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","volume":"8","author":"HE Ramsey","year":"2018","unstructured":"Ramsey, H. E. et al. A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia. Cancer Discov. 8, 1566\u20131581 (2018).","journal-title":"Cancer Discov."},{"key":"900_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli, I. et al. Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell 36, 84\u201399.e8 (2019).","journal-title":"Cancer Cell"},{"key":"900_CR39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740.e4 (2018).","journal-title":"Cancer Cell"},{"key":"900_CR40","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea, D. A. et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat. Med. 24, 1859\u20131866 (2018).","journal-title":"Nat. Med."},{"key":"900_CR41","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","volume":"125","author":"S Sriskanthadevan","year":"2015","unstructured":"Sriskanthadevan, S. et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood 125, 2120\u20132130 (2015).","journal-title":"Blood"},{"key":"900_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"900_CR43","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A. & Higgins, G. S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24, 2482\u20132490 (2018).","journal-title":"Clin. Cancer Res."},{"key":"900_CR44","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"900_CR45","doi-asserted-by":"publisher","first-page":"eaax2863","DOI":"10.1126\/scitranslmed.aax2863","volume":"11","author":"D Sharon","year":"2019","unstructured":"Sharon, D. et al. Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response. Sci. Transl. Med. 11, eaax2863 (2019).","journal-title":"Sci. Transl. Med."},{"key":"900_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Guieze","year":"2019","unstructured":"Guieze, R. et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell 36, 369\u2013384 e13 (2019).","journal-title":"Cancer Cell"},{"key":"900_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s42255-021-00378-8","volume":"3","author":"AN Gorelick","year":"2021","unstructured":"Gorelick, A. N. et al. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nat. Metab. 3, 558\u2013570 (2021).","journal-title":"Nat. Metab."},{"key":"900_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","volume":"11","author":"CH Arrowsmith","year":"2015","unstructured":"Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536\u2013541 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"900_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1242\/dmm.023564","volume":"9","author":"MJ Moulton","year":"2016","unstructured":"Moulton, M. J. & Letsou, A. Modeling congenital disease and inborn errors of development in Drosophila melanogaster. Dis. Model. Mech. 9, 253\u2013269 (2016).","journal-title":"Dis. Model. Mech."},{"key":"900_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.pep.2004.06.035","volume":"37","author":"DM Mueller","year":"2004","unstructured":"Mueller, D. M. et al. Ni-chelate-affinity purification and crystallization of the yeast mitochondrial F1-ATPase. Protein Expr. Purif. 37, 479\u2013485 (2004).","journal-title":"Protein Expr. Purif."},{"key":"900_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jmb.2004.10.060","volume":"345","author":"JL Rubinstein","year":"2005","unstructured":"Rubinstein, J. L., Dickson, V. K., Runswick, M. J. & Walker, J. E. ATP synthase from Saccharomyces cerevisiae: location of subunit h in the peripheral stalk region. J. Mol. Biol. 345, 513\u2013520 (2005).","journal-title":"J. Mol. Biol."},{"key":"900_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsb.2013.11.002","volume":"185","author":"CR Marr","year":"2014","unstructured":"Marr, C. R., Benlekbir, S. & Rubinstein, J. L. Fabrication of carbon films with approximately 500\u2009nm holes for cryo-EM with a direct detector device. J. Struct. Biol. 185, 42\u201347 (2014).","journal-title":"J. Struct. Biol."},{"key":"900_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S1431927608080781","volume":"14","author":"WF Tivol","year":"2008","unstructured":"Tivol, W. F., Briegel, A. & Jensen, G. J. An improved cryogen for plunge freezing. Microsc. Microanal. 14, 375\u2013379 (2008).","journal-title":"Microsc. Microanal."},{"key":"900_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"900_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"900_CR56","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"900_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/protein\/gzz013","volume":"32","author":"AV Medina-Cucurella","year":"2019","unstructured":"Medina-Cucurella, A. V. et al. User-defined single pot mutagenesis using unamplified oligo pools. Protein Eng. Des. Sel. 32, 41\u201345 (2019).","journal-title":"Protein Eng. Des. Sel."},{"key":"900_CR58","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/anie.202010338","volume":"60","author":"JH Boyce","year":"2021","unstructured":"Boyce, J. H., Reisman, B. J., Bachmann, B. O. & Porco, J. A. Jr. Synthesis and multiplexed activity profiling of synthetic acylphloroglucinol scaffolds. Angew. Chem. Int. Ed. 60, 1263\u20131272 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"900_CR59","first-page":"88","volume":"27","author":"C Baldwin","year":"1964","unstructured":"Baldwin, C. Biological and chemical properties of aurovertin, a metabolic product of Calcarisporium abuscula. Lloydia 27, 88\u201395 (1964).","journal-title":"Lloydia"},{"key":"900_CR60","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/BF00992580","volume":"17","author":"SB Krasnoff","year":"1991","unstructured":"Krasnoff, S. B. & Gupta, S. Identification and directed biosynthesis of efrapeptins in the fungus Tolypocladium geodes Gams (Deuteromycotina: Hyphomycetes). J. Chem. Ecol. 17, 1953\u20131962 (1991).","journal-title":"J. Chem. Ecol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00900-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:11:13Z","timestamp":1675901473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-021-00900-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1038\/s41589-021-00900-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.31.445492","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R.S. receives research funding from Astex, Incyte, Takeda and TG Therapeutics; has equity with Karyopharm; serves as an advisor or consultant to AbbVie, Astex, BMS, Celgene, Incyte, Karyopharm, Ryvu, Sierra Oncology, Takeda and TG Therapeutics. P.B.F. currently receives research funding from Incyte, and has received research funding from Astex and Forma Therapeutics in the past. Within the past 2 years, W.K.R. has received unrelated clinical research support Bristol-Meyers Squib, Merck, Pfizer, Peloton, Calithera and Incyte.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}